BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 06, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

BTG, Nycomed sales and marketing update

BTG said it will accelerate the reacquisition of U.S. marketing rights from Nycomed to CroFab, a polyclonal antibody against rattlesnake venom, and DigiFab, a polyclonal antibody against digoxin (digitalis) glycosides. BTG will regain rights to the products...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >